Taurocholic acid
|
Basic information |
| Metabolite name | Taurocholic acid |
 | HMDB0000036 |
 |
C05122 |
 |
6675 |
| Synonyms | Taurocholate |
| No. of studies | 17 |
|
Basic information |
| Metabolite name | Taurocholic acid |
| HMDB0000036 |
|
C05122 |
|
6675 |
| Synonyms | Taurocholate |
| No. of studies | 17 |
|
Relationship between Taurocholic acid and depression (count: 17) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M006 | Type1 | depressed group vs. control group | Plasma | Human | Down |
| Study M1022 | Type1 | CUS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M1022 | Type2 | CUS + Tongxieyaofang neutral polysaccharide + Tongxieyaofang acidic polysaccharide group vs. CUS group | Faece | C57BL/6 mouse | Up |
| Study M1022 | Type2 | CUS + middle dose of Tongxieyaofang neutral polysaccharide group vs. CUS group | Faece | C57BL/6 mouse | Up |
| Study M1022 | Type2 | CUS + fructooligosaccharide + galactooligosaccharides group vs. CUS group | Faece | C57BL/6 mouse | Up |
| Study M1022 | Type2 | CUS + high dose of Tongxieyaofang neutral polysaccharide group vs. CUS group | Faece | C57BL/6 mouse | Up |
| Study M1022 | Type2 | CUS + low dose of Tongxieyaofang neutral polysaccharide group vs. CUS group | Faece | C57BL/6 mouse | Up |
| Study M1032 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M1101 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M457 | Type3 | D6 doses of PBR group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M604 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M608 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M608 | Type2 | CUMS + Poria cocos group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M632 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Unknown |
| Study M774 | Type1 | MDD group vs. control group | Serum | Human | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Up |
| Study M867 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Plasma | Sprague-Dawley rat | Unknown |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Down |